Alumis (ALMS) Invested Capital (2023 - 2025)
Alumis (ALMS) reported Invested Capital of $301.3 million for Q4 2025, up 15.84% year-over-year from $260.1 million in Q4 2024, and down 21.69% quarter-over-quarter from $384.8 million in Q3 2025.
Alumis (ALMS) Invested Capital (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Invested Capital data on file, last reported at $301.3 million in Q4 2025.
- Invested Capital for Q4 2025 came in at $301.3 million, up 15.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $301.3 million (up 15.84% YoY), and the FY2025 annual result was $301.3 million, up 15.84% from the prior year.
- Invested Capital eased to $301.3 million in Q4 2025 per ALMS's latest filing, from $384.8 million in the prior quarter.
- Over five years, Invested Capital peaked at $485.3 million in Q2 2025 and troughed at -$438.8 million in Q2 2024.
- A 3-year average of $19.9 million and a median of $168.3 million in 2025 frame the typical range for Invested Capital.
- On a YoY basis, Invested Capital climbed as much as 214.95% in 2024 and fell as far as 67.24% in 2024.
- A 3-year view of Invested Capital shows it stood at -$339.3 million in 2023, then jumped by 176.67% to $260.1 million in 2024, then rose by 15.84% to $301.3 million in 2025.
- Business Quant data shows ALMS's Invested Capital at $301.3 million in Q4 2025, $384.8 million in Q3 2025, and $485.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 301.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 301.30 Mn |
| Sep 30, 2025 | 384.77 Mn |
| Jun 30, 2025 | 485.33 Mn |
| Mar 31, 2025 | 168.31 Mn |
| Dec 31, 2024 | 260.10 Mn |
| Sep 30, 2024 | 348.39 Mn |
| Jun 30, 2024 | -438.76 Mn |
| Mar 31, 2024 | -385.93 Mn |
| Dec 31, 2023 | -339.26 Mn |
| Sep 30, 2023 | -303.07 Mn |
| Jun 30, 2023 | -262.35 Mn |